Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis

Xiao, Guangqin, Zhu, Sixian, Xiao, Xiao, Yan, Lunan, Yang, Jiayin, Wu, Gang·2017·Hepatology

DOI 10.1002/hep.29302

Cited by (893)

Items 801–893 of 893

Prevalence, risk factors and liver-related complications of nonalcoholic fatty liver disease in Ethiopian HIV-infected patients: a cross-sectional study in a tertiary care center
Yohannes Birhanu, Zekewos Demissie, Wondwossen Amogne · 2023 · Research Square
Doença hepática gordurosa não alcoólica em pacientes com diabetes mellitus tipo 2
Mauy Frujuello Mana · 2021
Estudio de las características fenotípicas y genotípicas en pacientes con hígado graso no alcohólico con sobrepeso vs.obesidad
Beatriz Burgueño Gómez · 2023
Ensayo clínico comparativo de dos dietas hipocalóricas: dieta con patrón Mediterráneo, frente a dieta hipograsa en pacientes con esteatosis hepática metabólica (EHMET). Papel del polimorfismo PNPLA3 en la respuesta a la dieta.
Cristina Laserna Del Gallego · 2024
Stem Cells and Extracellular Vesicles for Prevention and Treatment of Liver Fibrosis
Siti Aishah Sulaiman, Muhammad Nafiz Haidi Adrus, Vicneswarry Dorairaj, Nadiah Abu, Nurul‐Syakima Ab Mutalib, Khairul Najmi Muhammad Nawawi, Nor Azian Abdul Murad · 2024 · Elsevier eBooks
Suspected NAFLD
James Phillip Esteban · 2023 · Springer eBooks
Clinical characteristics and mortality outcomes associated with subtypes of steatotic liver disease in the United States
Pengwei Zhang, Sijia Yang, Peipei Yu, Yijun Zeng, Chunhong Ye, Panpan Wang, Mingwei Wang, Li Li, Xianhui Dong · 2024 · Research Square
Nonalcoholic fatty liver disease: What comes before and what are the consequences?
Fernando Bril · 2024 · Elsevier eBooks
Metabolic syndrome decouples insulin resistance from liver fibrosis in patients with Metabolic Associated Steatohepatitis
Cheng Zeng, Yang Yang, Zhiqiang Jin, Hua Xu, Shan Zhong, Yurui Xie, Chaohua Zhang, Zhi Zhou · 2024 · Research Square
Clinical diagnosis and evaluation pathway
Robert Lam, Bubu A. Banini, Albert Do, Joseph K. Lim · 2024 · Elsevier eBooks
Noninvasive evaluation of liver fibrosis in MASLD—Imaging/elastography based
Xinrong Zhang, Guanlin Li, Huapeng Lin, Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong · 2024 · Elsevier eBooks
Suitability of Non-Invasive Tests in the Evaluation of Liver Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Álvaro Yagüe Parada, Andrés Felipe Castañeda Agredo, Rocío Calvo, Agustina González, Andrés Varela, Marta Morán, Michelle Casanova, Benjamín Polo Lorduy · 2024 · EMJ Hepatology
Prediction model for the development of liver fibrosis in patients with metabolic dysfunction–associated steatotic liver disease
Кролевец Татьяна Сергеевна, Maria A. Livzan, Maria I. Syrovenko, Л. В. Щербакова · 2024 · Russian Medical Inquiry
Significance of Correlation of Shear Wave Elastography With Fibrosis-4 in a Cohort of Patients With Diabetes and Nonalcoholic Fatty Liver Disease
Rohan Kelkar, Uday Phadke, Raveena Kelkar, Shalmi Khanapurkar, Nishad Barve · 2024 · Cureus
Application of metabolomics in liver cirrhosis and its complications
Guo Lin, Jihong Chen, Yu-Hang Yin, Hao-Nan Zhao, Zhuang Liu, Xingshun Qi · 2024 · World Chinese Journal of Digestology
Metabolic dysfunction-associated steatotic liver disease and drug-induced injuries: Pathogenetic aspects, treatment and prevention
Iryna G. Pakhomova · 2024 · Meditsinskiy sovet = Medical Council
Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis
Mohamed Abdel-Samiee, Essam Salah Ibrahim, Mohamed Kohla, Eman Abdelsameea, Mohsen Salama · 2024 · World Journal of Gastrointestinal Pharmacology and Therapeutics
Diagnostic Advances in MASLD
Paulina Vidal‐Cevallos, Norberto Carlos Chávez-Tapia, Emmanuel A. Tsochatzis · 2024 · Springer eBooks
Author's reply: “Inflammatory bowel disease, MASLD, and cardiometabolic risks: Unveiling a new perspective on mortality risk”
Qian Zhang, Shanshan Wu · 2025 · Digestive and Liver Disease
Correlation of Liver Fibrosis using Noninvasive Transient Elastography with Histological Staging in Infants with Cholestasis - A Prospective Analytical Study
Deepti Naik, Santosh Kumar Mahalik, Mukund Sable, Amit Kumar Satpathy, Manas Kumar Panigrahi · 2025 · Journal of Indian Association of Pediatric Surgeons
SWOT Analysis of Noninvasive Tests for Diagnosing MASLD with Severe Fibrosis: An Expert Review by the JANIT Forum
Yoshihiro Kamada, Yoshio Sumida, Hirokazu Takahashi, Hideki Fujii, Miwa Kawanaka, Atsushi Nakajima, JANIT Forum · 2025 · Kanzo
Fibrosis-4 and NAFLD Fibrosis Scores Have Good Specificity to Rule Out Advanced Fibrosis in Healthy Liver Donors: A Biopsy-Based Study
Gargi Singh, Manish Singh, Narendra Singh Choudhary, Neeraj Saraf, Arvinder Singh Soin · 2025 · Journal of Clinical and Experimental Hepatology
Metabolic-associated steatotic liver disease (MASLD): how I evolved my approach to diagnosis and staging
Maria Kalafateli, Burcu Sena Aydin, Boran Polat, Michael S. Yee, Roberta Forlano, Chioma N. Izzi‐Engbeaya, Mark R. Thursz, Benjamin Harvey Mullish, Pinelopi Manousou · 2025 · Frontline Gastroenterology
Metabolic-associated fatty liver disease: Noninvasive diagnosis and assessment of liver fibrosis
O. O. Karshina, Ibragim S. Sabirov · 2025 · Meditsinskiy sovet = Medical Council
Validation of the FibroScan-AST (FAST) and Agile 3+ score in metabolic dysfunction-associated steatotic liver disease in a Russian cohort of patients
Гомонова Вероника Павловна, K. L. Raikhelson, В. А. Кащенко, A. V. Lodygin, Vadim Evgenievich Karev · 2025 · Meditsinskiy sovet = Medical Council
Maternal liver fibrosis indices as predictors of adverse perinatal outcomes in patients with gestational diabetes mellitus
Murad Gezer, Ümit Taşdemir, Ömer Gökhan Eyisoy, Sevdenur Yiğit, Mucize Eriç Özdemir, Oya Demirci · 2025 · Acta Diabetologica
Evaluation of Liver Stiffness in Obesity: A Comparison of Canon Aplio i800 2d-Shear Wave Elastography and Siemens Sequoia Point Shear Wave Elastography
Atul Kapoor, Aprajita Kapur · 2025 · International Journal of Gastroenterology
Precise Non-invasive Liver Cirrhosis Quantification via Multimodal Stiffness-Structural Fusion Imaging
Yangzhizi Qiao, Fangliang Xing, Yang Liu, Tengxiao Liang · 2025 · Journal of Visualized Experiments
Higher afamin concentrations are associated with higher fatty liver indices: Population‐based KORA F4/FF4 study
Corinna Niersmann, Anna Zhu, Haïfa Maalmi, Xinting Cai, Jana Nano, Wolfgang Rathmann, Wolfgang Köenig, Toshinari Takamura, Barbara Kollerits, Hans Dieplinger et al. · 2025 · European Journal of Clinical Investigation
Relación entre el control de la psoriasis y la enfermedad hepática esteatósica asociada a disfunción metabólica
Citlalli Guadalupe Hernández Guzmán, Blanca Elena Verazaluce Rodríguez, Lauro Fabián Amador Medina, Graciela López Mata, Erick Josefat Díaz Huerta, Óscar Noel Chávez Hernández · 2025 · Piel
A novel multi-parameter MRI-based model for identification of high-risk metabolic dysfunction-associated steatohepatitis
Wenxin Ma, Xutong Huang, Zhen Feng, Wenli Tan, Jinzhe Li, Huamei Yan, Yanxi Zheng, Zhiwei Qin, Fuhua Yan, Huimin Lin et al. · 2025 · European Radiology
Innovative approach on monitoring methotrexate induced hepatotoxicity in psoriasis patients – A case report
Ana-Maria Sandu, Oana Mirela Tiucă, Radu Alexandru Stan, A Andone, Robert Aurelian Tiucă, Ovidiu Simion Cotoi, Silviu Horia Morariu · 2025 · Acta Marisiensis. Seria Medica
Metabolic dysfunction-associated steatotic liver disease in metabolic syndrome
Oksana M. Drapkina, Sergey Vladimirovich Nedogoda · 2025 · Russian Journal of Cardiology
Pregnancy Dysglycemia and Estimated Risk of Metabolic Dysfunction–Associated Steatotic Liver Disease 10–14 Years After Delivery
CHRISTINE P. FIELD, Lanla F. Conteh, Jiqiang Wu, Vidya N Mullangi, Patrick M. Catalano, Mark B. Landon, Denise M. Scholtens, William L. Lowe, William A. Grobman, Kartik Kailas Venkatesh · 2025 · O&G Open
Nichtinvasive Marker zur Bestimmung der Fibrose und Zirrhose
Samira Abu Jhaisha, Christian Trautwein · 2025 · Springer eBooks
Metabolic dysfunction-associated steatotic liver disease: Role in the development of comorbid conditions and therapeutic management
Tatiana Yu. Demidova, Victoria V. Titova, A. N. Levitskaya, M. A. Gyozalyan · 2025 · Meditsinskiy sovet = Medical Council
Perspective Chapter: Multiparametric Ultrasound in the Evaluation of Fatty Liver Disease
Ioan Sporea, Alexandru Popa, Alina Popescu · 2024 · IntechOpen eBooks
Comparative Diagnostic Accuracy of Magnetic Resonance Elastography and Diffusion-Weighted Imaging in Differentiating Benign and Malignant Focal Liver Lesions: A Systematic Review and Meta-Analysis
Amir Hassankhani, Parya Valizadeh, Payam Jannatdoust, Melika Amoukhteh, Abbas Mohammadi, Ali Gholamrezanezhad, Ali Haq · 2025 · medRxiv
Additional file 1 of Application of artificial intelligence in chronic liver diseases: a systematic review and meta-analysis
Decharatanachart, Pakanat, Roongruedee Chaiteerakij, Thodsawit Tiyarattanachai, Treeprasertsuk, Sombat · 2021 · Figshare
Additional file 6 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
Additional file 1 of Significance of Fib4 index as an indicator of alcoholic hepatotoxicity in health examinations among Japanese male workers: a cross-sectional and retrospectively longitudinal study
Hideki Shinoda, Yuya Watanabe, Kota Fukai, Kayoko Kasuya, Yuko Furuya, Shoko Nakazawa, Toru Honda, Hayashi, Takeshi, Toru Nakagawa, Masayuki Tatemichi et al. · 2023 · Figshare
Additional file 5 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
Additional file 1 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
Additional file 3 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
Additional file 1 of Response to semaglutide of non-drinker subjects with type 2 diabetes
Petralli, Giovanni, Francesco Raggi, Alice Del Zoppo, Rovera, Chiara, Antonio Salvati, Brunetto, Maurizia Rossana, Anna Solini · 2024 · Figshare
Additional file 1 of A noninvasive model discriminating significant histological changes in treatment-naive chronic hepatitis B patients with normal ALT
Teng, Jiaming, Du, Yanan, Phimphone Visalath, Zhou, Tianhui, Du, Bingying, Zhang, Qin, Wei Cai · 2023 · Figshare
Additional file 7 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
Additional file 2 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
Additional file 4 of The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
Hu, Haofei, Han, Yong, Cao, Changchun, Yongcheng He · 2022 · Figshare
Magnetic resonance elastography and morphological alteration of the hepatic parenchyma
João Paulo Leal Schambeck, Gabriele Carra Forte, João Bruno F. Kotlinski, Guilherme Stüker, Pedro Simões dos Santos Pilau, Cristina Carra Forte, Ângela de Figueiredo Pinto AGOSTINI, Luis Carlos Anflor, Fernando Ferreira Gazzoni, Rubens Gabriel Feijó Andrade et al. · 2025 · Scientia Medica
Aspirin Use Does Not Significantly Reduce the Risk of Liver Fibrosis in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease
Linlin Yin, Bin Zhang · 2025 · Food Science & Nutrition
Viscosity Imaging for Detection of Liver Inflammation: A Systematic Review
Atul Kapoor · 2025 · International Journal of Gastroenterology
Agile 3+ Index Is Independently Associated With Cardiovascular Diseases in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease: Analysis of NHANES 2017–2020
Yan Li, Minglan Yang, Jiang Yue, Zixuan Wang, Yicheng Qi, Qianjing Liu, Jing Ma · 2026 · Diabetes/Metabolism Research and Reviews
Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease in Individuals With Type 2 Diabetes Using Vibration-Controlled Transient Elastography and Serial Elastography Measurements to Monitor Response to Therapy: Methodological Details
Abhishek Singhai, Richa Meena, Rajnish P. Joshi, Sagar Khadanga, Ratinder Jhaj · 2026 · Cureus
Understanding liver and digestive diseases: a paved road to improve diagnosis, management, and treatment
Ina Bergheim, Jean François David Cadranel, Jianguo Chen, Wen‐Xing Ding, Robert Eferl, Carmen García‐Ruiz, Hartmut Jaeschke, Firouzeh Kazerouni, Amedeo Lonardo, Derek A. Mann et al. · 2026 · Exploration of Digestive Diseases
Metabolic factors associated with colorectal neoplasms: a single center retrospective cross-sectional analysis of colonoscopy patients
Junya Arai, Hiroaki Fujiwara, Tomonori Aoki, Ryota Niikura, Sozaburo Ihara, Nobumi Suzuki, Yosuke Tsuji, Yoku Hayakawa, Masato Kasuga, Mitsuhiro Fujishiro · 2026 · BMC Gastroenterology
Non-invasive risk stratification of metabolic dysfunction-associated steatotic liver disease and liver fibrosis in adults with type 1 diabetes
Manuel Ramón García-Sáenz, Marilu Cervantes-Maldonado, Luis Angel López-Cruz, Eduardo Salif Luna-Ávila, Paulo César Gete Palacios, Cristina Martínez-Berdeja, Omar Jaime-Leal, Aldo Ferreira‐Hermosillo · 2026 · Frontiers in Endocrinology
Cohort profile: The DIabetes and ST-segment Elevation Myocardial Infarction (DISTEMI) Study
Clara Möser, Katsiaryna Prystupa, Martin Schön, Iryna Yurchenko, Kálmán Benedikt Bódis, Maximilian Huttasch, FILIPPO C. MICHELOTTI, Yuliya Kupriyanova, Vera B. Schrauwen‐Hinderling, Cesare Granata et al. · 2026 · Cardiovascular Diabetology
Personalized Medicine Approaches in Metabolically Associated Fatty Liver Disease: A Comprehensive Review
Vaibhavkumar Patel, Archana Mohit Navale, Pratichi Singh · 2026 · SN Comprehensive Clinical Medicine
The Liver-Heart Axis: A Narrative Review of Clinical Implications of the MASLD Redefinition for Internists
Hassan A. Abdou, Saied A. Omar · 2026 · ASIDE Gastroenterology
Molecular mechanism and metabolic abnormality detection of CYP2C19 based on electrochemical sensors: Metabolic driving factors of MASLD liver fibrosis
Cheng Zeng, Shaogang Zhou, Haowen Luo, Shan Zhong, Pan Yang, Wenwei Yin, Zhi Zhou, Yang Yang · 2026 · Microchemical Journal
Cost-utility and budget impact analyses of significant fibrosis detection in individuals with metabolic syndrome or obesity in Thailand
Chayanis Kositamongkol, Pichaya Tantiyavarong, Alissa Ratanatawan, Pimsiri Sripongpun, Prawej Mahawithitwong, Prawat Kositamongkol, Surasak Saokaew, Pochamana Phisalprapa · 2026 · PLoS ONE
Effects of U62631.5 on short-chain fatty acid receptor 41(GPR41) and the related intestinal bacterium Butyricicoccus pullicaecorum after fecal bacterial transplantation in nonalcoholic fatty liver disease
Xiaoyan Hao, Cong Ma, Xiangyang Gao, Fei Wang, Bingqing Han, Dong Gyu Bai, Lei Ou, Qiang Zeng · 2026 · BMC Microbiology
Metabolic dysfunction-associated fatty liver disease and the risk of incident chronic kidney disease: A 10-year prospective cohort study
Hongsheng Cui, Yali Xu, Jin Zhang, Qiang Cao, Jiazhen Zhang, Xu Cheng, Xiaomin Zhang, Huan Guo, Tangchun Wu, Jia He et al. · 2026 · Diabetes Research and Clinical Practice
Quantitative equivalence of Quantitative Imaging Biomarkers Alliance (QIBA)-2023- and QIBA-2020-compliant MR elastography protocols for liver stiffness assessment
Takahisa Tokimori, Satoshi Saitoh, Shingo Ohira, Hidesato Suzuki, Isao Kurita, Masakatsu Tano, Takuyo Kozuka · 2026 · Abdominal Radiology
The role of biomarkers for the diagnosis and follow-up of patients with liver diseases
Laure Elkrief · 2021
Predictors of metabolic dysfunction-associated steatotic liver diseases (MASLD) in Vietnamese population
Anh Gia Pham, An Vu-Khanh Le, Yen Thi‐Hai Pham, Lanh Sy Nguyen, Huong Lan Nguyen, Nina Quach, Thau Manh Cao, Hanh Thi Nguyen, Xuan Thanh Thai, Anh Tuan Luong et al. · 2026 · Scientific Reports
Metabolic Surgery in Liver Disease: Optimizing Patient Selection, Perioperative Risk and Outcomes Through Artificial Intelligence
Hafsa Younus, Aamir Nawaz, Haris A Khwaja · 2026 · IntechOpen eBooks
Novel Approaches to Diagnosing and Treating Non-alcoholic Fatty Liver Disease: Opportunities and Accomplishments
Ildar Akhmetovich Uzyanbaev, Sofya Timoshenko, Л. В. Спирина, М.В. Матвеева · 2026 · Current Drug Targets
Can Noninvasive Tests Reduce the Need for Liver Biopsy? A Cross‐Sectional Diagnostic Accuracy Study Assessing NFS, FIB‐4, APRI, BARD, BAAT, API, and AAR for Advanced Fibrosis in MASLD Patients in Iran
Amir Mohammad Salehi, Hossain Salehi, Atefeh Sadeghi, Maryam Hasanzarrini, Salman Khazaei, Hossein Ali Mohammadi, Mahvash Alizade Naini · 2026 · International Journal of Clinical Practice
Diagnostic Performance of Non-invasive Tests for Hepatic Fibrosis Using Liver Biopsy As the Reference Standard: A Systematic Review and Meta-Analysis
Sri Lakshmi Kothakapa, Sulekha Ramireddy, Sanjay Reddy Thanugundla, Sainithya Chittireddy, Pruthvi Raj Nenavath, Aarti Prodduku, Charvika Lakavath, Neha Poloju, Naga Teja Thota, Prannav koolla et al. · 2026 · Cureus
Possible correlations between infertility and adverse metabolic profile: a case-control study
Carmen Imma Aquino, Nicole Vercellino, Fortina Elisabetta, Daniela Ferrante, Cristina Rigamonti, Minisini Rosalba, Mario Pirisi, Remorgida Valentino, Mattia Bellan, Surico Daniela · 2026 · European Journal of Obstetrics & Gynecology and Reproductive Biology
Comparative discriminative ability of CVAI and traditional insulin resistance indices for MAFLD in Chinese adults with type 2 diabetes
Jian Yang, Fanci Xie, Xiaoli Zhu, Hairong Zhou · 2026 · Frontiers in Endocrinology
Problems with FIB-4 as an initial screening tool for liver fibrosis in patients with type 2 diabetes
Josh Bilson, Ryan Malcolm Buchanan, Christopher D. Byrne · 2026 · Metabolism and Target Organ Damage
Serum Biomarkers for the Non-Invasive Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): An Update
Austin J Halupnik, Antonio Sánchez · 2026 · Clinical Chemistry
Development of a machine learning-based noninvasive diagnostic model for liver fibrosis in metabolic-associated steatotic liver disease
Yixin Hui, Yuping Zeng, M Zhang · 2026 · European Journal of Gastroenterology & Hepatology
From FIB-4 to the Artificial Intelligence Era: The Evolution of Non-Invasive Tools (NITs) for Tailored Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Mario Romeo, Fiammetta Di Nardo, Claudio Basile, Carmine Napolitano, Paolo Vaia, Luigi Di Puorto, Mattia Indipendente, Alessia De Gregorio, Marcello Dallio, Alessandro Federico · 2026 · Livers
Non-invasive Tests for the Prediction of Liver-related Events in Patients with MASLD: A Systematic Review and Meta-analysis
X W Wang, Xue Dong, 钱洛丹, Zhenghan Yang, Dawei Yang, Yantao Niu · 2026 · Academic Radiology
Closer Association of Liver Stiffness Than Liver Fat Content With Imaging‐Derived Neurovascular Coupling in a Metabolic Dysfunction‐Associated Steatotic Liver Disease Cohort
Zhuoru Jiang, Futao Chen, Haitao Zhang, Zhiwen Fan, Qian Chen, J Lu, Weiping Li, Danni Ge, Qi Li, Zhengyang Zhu et al. · 2026 · Diabetes Obesity and Metabolism
Diffusion-Weighted Imaging–Based Virtual MR Elastography of the Liver: Beyond Mechanical Waves
Takashi Ota, Denis Le Bihan, Masatoshi Hori, Atsushi Nakamoto, Hideyuki Fukui, Hiromitsu Onishi, Noriyuki Tomiyama · 2026 · Korean Journal of Radiology
The Use of Ultrasound-Based Elastography Techniques in Liver Fibrosis: A Narrative Review
Arjuna Priyadarsin De Silva, Shashini Hathurusinghe, Madunil Anuk Niriella, Hithunadura Janaka De Silva · 2026 · Diagnostics
Noninvasive Detection of Clinically Significant Fibrosis in Biopsy-Proven MASLD: A Retrospective Cross-Sectional Diagnostic Accuracy Study
Onur Ekşi, Kadri Atay, Tuğçe Eşkazan, Elgün Abishov, Mustafa Canbakan, Billur Canbakan · 2026 · Medicina
Clinical utility of shear wave speed and dispersion slope measured by shear wave elastography for the assessment of hepatic congestion in dogs with cardiac disease
Nozomi Shiohara, Kensuke Nakamura, Masahiro Tamura, Nozomu Yokoyama, Noboru Sasaki, Sei Kawamoto, Mitsuyoshi Takiguchi · 2026 · Journal of Veterinary Cardiology
FIB-4 INDEX IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM: A CASE-CONTROL STUDY
Çağatay Emir Önder, Püren Gökbulut, Işılay Taşkaldıran · 2026 · Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
Liver-associated findings and outcomes in a telomere biology disorders clinic
Kianna M. Nguyen, Laura J. Ongie, Peng Xu, Daniel D. Penrice, Yael N. Kusne, Ana C. Zamora, Blanca Lizaola‐Mayo, Filippo Pinto e Vairo, Eva M. Carmona, Rachel A Simon et al. · 2026 · Hepatology Communications
Non-invasive Assessment and Therapeutic Targeting in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Overcoming the Dissonance Between Drug Development and Precision Medicine
Eleni Theocharidou, Konstantinos Arvanitakis, Theocharis Koufakis, Emmanuel A. Tsochatzis, Sven Francque, Georgios S. Germanidis · 2026 · Drugs
Diagnosis and monitoring of metabolic dysfunction-associated steatohepatitis disease: a critical review
Élisa Marin‐Couture, Fannie Lajeunesse‐Trempe, Georgios K. Dimitriadis, Royce P Vincent · 2026 · Critical Reviews in Clinical Laboratory Sciences
Investigation of non-invasive tests for fibrosis diagnosis and prognostication of events in metabolic dysfunction-associated steatotic liver disease: A prospective study cohort
Marie Louise N. Therkelsen, Liv Eline Hetland, Mikkel Parsberg Werge, Mira Thing, Elias Badal Rashu, Puria Nabilou, Nina Kimer, Anders Ellekaer Junker, Alejandro Mayorca Guiliani, M.A. Karsdal et al. · 2026 · Annals of Hepatology
Polycystic Ovary Syndrome Is Associated with Fatty Pancreas Disorder: A Case–Control Study in Non-Diabetic Women
Halil Severoglu, Fehmi Ateşž, Hüseyin Durukan · 2026 · Journal of Clinical Medicine
Optimal Control‐Based RF Pulses Versus Classical Motion‐Encoding Strategies for In Vivo Hepatic MR Elastography Across Multiple Excitation Frequencies in Mice: Reproducibility Assessment
Tiffany Bakir Ageron, Pilar Sango Solanas, Éric Van Reeth, Denis Grenier, Kevin Tse Ve Koon, Olivier Beuf · 2026 · NMR in Biomedicine
Missed Diagnosis in Alcohol‐Related Hepatocellular Carcinoma: A Call for Alcohol Consumption and Liver Disease Early Detection
Victoria Mignot, Aurore Baron, Thomas Decaens, Charlotte E. Costentin · 2026 · Liver International
Associations between tissue stiffness, tumor response to transarterial chemoembolization and prognosis in hepatocellular carcinoma: insights from multifrequency 3D-magnetic resonance elastography
Jie Chen, Zhen Zhang, Zheng Ye, Yali Qu, Liping Deng, Yuan Yuan, Guoyong Chen, Hehan Tang, Bin Song · 2026 · Abdominal Radiology
Metabolic Dysfunction‐Associated Steatotic Liver Disease
Fasiha Kanwal, Vincent Wai Sun Wong · 2026 · Wiley eBooks